Using antibody analysis to prevent and detect tuberculosis in children with HIV

Leveraging antibody-omics to prevent and detect TB in children affected by HIV

NIH-funded research Emory University · NIH-11189943

This study is looking for better ways to spot and prevent tuberculosis (TB) in children with HIV by checking their blood for special antibodies that might show how their immune system is fighting the disease, with the hope of improving diagnosis and health for these kids.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11189943 on NIH RePORTER

What this research studies

This research investigates new ways to diagnose and prevent tuberculosis (TB) in children who are affected by HIV. It focuses on understanding how the immune system responds to TB by analyzing specific antibodies in blood samples from children in various countries. The study aims to identify unique antibody features that could indicate protection against TB and help in diagnosing active infections. By leveraging existing clinical data and samples, the research seeks to improve current diagnostic methods and ultimately enhance public health outcomes for vulnerable children.

Who could benefit from this research

Good fit: Ideal candidates for this research include children under 11 years old who are either affected by HIV or have been exposed to it.

Not a fit: Patients who are not children or those without any connection to HIV or tuberculosis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and preventive strategies for tuberculosis in children living with HIV.

How similar studies have performed: Previous research has shown promise in using antibody profiling for TB diagnosis, suggesting that this approach could yield significant insights.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.